Fibrinolysis Compared to Thoracoscopy for Pleural Infection
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Duration of Hospital Stay After Intervention |
4; 2 | — |
| SECONDARY Total Length of Hospital Stay |
6; 3.5 | — |
| SECONDARY Number of Participants Necessitating Intervention After the Assigned Treatment |
3; 4 | — |
| SECONDARY Adverse Events |
1; 1 | — |
| SECONDARY In Hospital and 30-day Mortality |
0; 1 | — |
Eligibility Criteria
Inclusion Criteria
Subjects >18 years old with:
Evidence of empyema or complex parapneumonic effusion
Exclusion Criteria
Age <18 years Pregnancy Inability to give informed written consent Previous thoracic surgery or thrombolytic therapy for pleural infection Medical thoracoscopy cannot be performed within 48 hours Hemodynamic instability or severe hypoxemia Non corrected coagulopathy Homogeneously echogenic effusion on pleural ultrasonography
Data sourced from ClinicalTrials.gov (NCT03468933). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.